3RDEYEBIO
Live / Registered — Registered (as of 22 Mar 2022)
What this means for you
Registered since 22 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90285295
- Registration number
- 6675095
- Mark type
- Design + words
- Filed
- 28 Oct 2020
- Published for opposition
- 04 Jan 2022
- Registered
- 22 Mar 2022
- Attorney of record
- Maha Jafarey
Goods and services
- Class 035 — Advertising and business services: Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Advisory board development and management being personnel management services; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields, Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and acute and chronic devastating diseases and conditions beyond cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- 3RDEYEBIO LLC, Seattle, WA, US
- 3RDEYEBIO LLC, Seattle, WA, US
- 3RDEYEBIO LLC, Seattle, WA, US
Prosecution history
- 22 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jan 2022 — PUBLISHED FOR OPPOSITION
- 15 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Dec 2021 — EXAMINER'S AMENDMENT ENTERED
- 01 Dec 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Dec 2021 — EXAMINERS AMENDMENT E-MAILED
- 01 Dec 2021 — EXAMINERS AMENDMENT -WRITTEN
- 01 Jul 2021 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 01 Jul 2021 — LETTER OF SUSPENSION E-MAILED
- 01 Jul 2021 — SUSPENSION LETTER WRITTEN
- 01 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED